We found that the reduction in INTS9 was linked to a decrease in tumor stem cells and proliferative tumor stem cells in IDH wildtype and only correlated with a decline in tumor stem cells in IDH mutant astrocytomas (Fig. 10F). Here, INTS9 is linked to astrocytoma (excluding glioblastoma).